Literature DB >> 8665787

Mediators, cytokines, and growth factors in liver-lung interactions.

R J Panos1, S K Baker.   

Abstract

Multiple mediators have been implicated in the interactions between the liver and the lungs in various disease states. The best characterized mediator of liver-lung interaction is alpha 1-antitrypsin. Several cytokines and mediators may be involved in the pathogenesis of the hepatopulmonary syndrome and in the cytokine cascades that are activated in systemic inflammatory states such as acute respiratory distress syndrome. Hepatocyte growth factor or scatter factor is a recently described peptide with a broad range of biologic effects that may mediate lung-liver interactions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8665787     DOI: 10.1016/s0272-5231(05)70305-1

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  20 in total

1.  Portopulmonary hypertension: challenges in diagnosis and management.

Authors:  Patrick J Troy; Aaron B Waxman
Journal:  Therap Adv Gastroenterol       Date:  2009-09       Impact factor: 4.409

Review 2.  The extrahepatic consequences of cirrhosis.

Authors:  Jin Kee Ho; Eric Yoshida
Journal:  MedGenMed       Date:  2006-03-02

3.  Two Cases of Pulmonary Hypertension Associated with Type III Glycogen Storage Disease.

Authors:  Teresa M Lee; Erika S Berman-Rosenzweig; Alfred E Slonim; Wendy K Chung
Journal:  JIMD Rep       Date:  2011-06-22

4.  Implications of estradiol and progesterone in pulmonary vasodilatation in cirrhotic patients.

Authors:  R Aller; J L Moya; S Avila; J Villa; V Moreira; R Bárcena; D Boxeida; D A de Luis
Journal:  J Endocrinol Invest       Date:  2002-01       Impact factor: 4.256

5.  Portopulmonary hypertension in decompensated cirrhosis with refractory ascites.

Authors:  F S Benjaminov; M Prentice; K W Sniderman; S Siu; P Liu; F Wong
Journal:  Gut       Date:  2003-09       Impact factor: 23.059

6.  Pentoxifylline in hepatopulmonary syndrome.

Authors:  Hamid Reza Kianifar; Maryam Khalesi; Eftekhar Mahmoodi; Monavar Afzal Aghaei
Journal:  World J Gastroenterol       Date:  2012-09-21       Impact factor: 5.742

7.  Pre- and postoperative systemic hemodynamic evaluation in patients subjected to esophagogastric devascularization plus splenectomy and distal splenorenal shunt: a comparative study in schistomomal portal hypertension.

Authors:  Roberto de Cleva; Paulo Herman; Luis Augusto Carneiro D'albuquerque; Vincenzo Pugliese; Orlando Luis Santarem; William Abrão Saad
Journal:  World J Gastroenterol       Date:  2007-11-07       Impact factor: 5.742

8.  Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.

Authors:  Ki Tae Suk; Moon Young Kim; Soung Won Jeong; Jae Young Jang; Yoon Ok Jang; Soon Koo Baik
Journal:  Dig Dis Sci       Date:  2017-12-01       Impact factor: 3.199

Review 9.  Cirrhosis and hepatopulmonary syndrome.

Authors:  Gokhan Tumgor
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 10.  Beyond a broken heart: circulatory dysfunction in the failing Fontan.

Authors:  Makoto Mori; Alfredo J Aguirre; Robert W Elder; Ali Kashkouli; Alton Brad Farris; Ryan M Ford; Wendy M Book
Journal:  Pediatr Cardiol       Date:  2014-02-15       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.